Bile acids enhance fat metabolism and skeletal muscle development in Zhijiang duck by modulating gut microbiota
CrossRef Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease Ioan-Andrei Iliuta, Xuewen Song, Lauren Pickel, Amirreza Haghighi, Ravi Retnakaran, James Scholey, Hoon-Ki Sung, Gregory R
This article explores the key differences between Melanotan 1 vs 2, helping clarify which peptide may be more suitable for specific research goals
37 CKD is often present in patients with HF, because CKD, T2D, obesity and adiposity frequently coexist in these patients, particularly in those with HFpEF